Cargando…

Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases

Advanced gastric adenocarcinoma (GAC) often leads to peritoneal carcinomatosis (PC) and is associated with very poor outcome. Here we report the comprehensive proteogenomic study of ascites derived cells from a prospective GAC cohort (n = 26 patients with peritoneal carcinomatosis, PC). A total of 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuangtao, Wang, Ruiping, Song, Shumei, Hao, Dapeng, Han, Guangchun, Song, Xingzhi, Zhang, Jianhua, Pizzi, Melissa Pool, Shanbhag, Namita, Futreal, Andrew, Badgwell, Brian, Harada, Kazuto, Calin, George, Vykoukal, Jody, Yu, Chuan-Yih, Katayama, Hiroyuki, Hanash, Samir M., Wang, Linghua, Ajani, Jaffer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251128/ https://www.ncbi.nlm.nih.gov/pubmed/37305699 http://dx.doi.org/10.1016/j.isci.2023.106913

Ejemplares similares

Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2021)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
por: Wang, Ruiping, et al.
Publicado: (2020)

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2020)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020)

A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model
por: Jin, Jiankang, et al.
Publicado: (2023)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue
por: Jin, Jiankang, et al.
Publicado: (2020)

Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy
por: Kato, Taketo, et al.
Publicado: (2020)

Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications
por: Kato, Taketo, et al.
Publicado: (2021)

LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2019)

Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2021)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Drug resistance and Cancer stem cells
por: Li, Yuan, et al.
Publicado: (2021)

Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016)

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
por: Han, Guangchun, et al.
Publicado: (2021)

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2022)

Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
por: Jin, Jiankang, et al.
Publicado: (2023)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

The Proteogenomic Mapping Tool
por: Sanders, William S, et al.
Publicado: (2011)

The bacterial proteogenomic pipeline
por: Uszkoreit, Julian, et al.
Publicado: (2014)

Proteogenomic characterization of cholangiocarcinoma
por: Deng, Mengjie, et al.
Publicado: (2023)

Protein citrullination as a source of cancer neoantigens
por: Katayama, Hiroyuki, et al.
Publicado: (2021)

Comparative proteogenomic characterization of glioblastoma
por: Asif, Samia, et al.
Publicado: (2019)

Systems proteogenomics for precision oncology
por: Klauschen, Frederick
Publicado: (2019)

Proteogenomics for pediatric brain cancer
por: SIMONIAN, Margaret
Publicado: (2021)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge
por: Eicher, Tara, et al.
Publicado: (2019)

The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
por: León-Letelier, Ricardo A., et al.
Publicado: (2023)

Integrative proteogenomic characterization of early esophageal cancer
por: Li, Lingling, et al.
Publicado: (2023)

Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas
por: Fahrmann, Johannes F., et al.
Publicado: (2020)

Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)

c-MYC-Driven Polyamine Metabolism in Ovarian Cancer: From Pathogenesis to Early Detection and Therapy
por: Chen, Yihui, et al.
Publicado: (2023)

Proteogenomic links to human metabolic diseases
por: Koprulu, Mine, et al.
Publicado: (2023)

Microscaled proteogenomic methods for precision oncology
por: Satpathy, Shankha, et al.
Publicado: (2020)

Proteogenomic analysis of pancreatic cancer subtypes
por: Kafita, Doris, et al.
Publicado: (2021)

S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
por: Ramberger, Evelyn, et al.
Publicado: (2023)

Quantitative Proteogenomic Characterization of Inflamed Murine Colon Tissue Using an Integrated Discovery, Verification, and Validation Proteogenomic Workflow
por: Rajczewski, Andrew T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qk7kip4uspst1ueutf5n3jl4v4